Stay informed with the latest litigation news. Explore now

IP Verse

Certain Protein Kinase Inhibitor - EP3288931B2

EP3288931

CHONGQING FOCHON PHARMACEUTICAL
Application Number
EP16785936A
Filing Date
Apr 28, 2016
Status
Patent Maintained As Amended
Jun 17, 2022
Grant Date
Jul 20, 2022
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3288931B2 was granted to Chongqing Fochon Pharmaceutical on Jul 20, 2022 following the initial filing on Apr 28, 2016 under the application number EP16785936A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HANNA MOORE CURLEYAug 4, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents